Beaten-Down Biotech Just Lost a Backer — Should You Care
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Choosing a total market fund for a Roth IRA doesn't have to be hard. Compare options, fees, and diversification to build a solid retirement strategy.
28,468 articlesWhen a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Both Microsoft and Palantir just hit 52-week lows, but the right move isn’t the same for every investor. This guide b...
When an insider doubles down on a falling stock, investors sit up and take notice. This article breaks down what it c...
The AI landscape is shifting from a few hardware champions to a broad ecosystem of software, cloud, and microchips. L...
BitGo’s Q1 2026 earnings reveal more than headline numbers. This guide translates the transcript into actionable insi...
Many investors wonder if a single crypto move can change everything. This guide breaks down XRP's potential, the risk...
As markets navigate a choppy May, tax rules around capital gains loom large for traders. Holding periods can swing ta...
Navitas Semiconductor is making headlines as its stock climbs. This piece breaks down why navitas semiconductor stock...
P&G leads with broad-based growth and new investments across beauty and global markets, while Colgate-Palmolive leans...
Meta Platforms dominates online ads with a vast social network and deep data insights. This guide explains why it rem...
A wave of cheaper AI models is reshaping demand for hardware, boosting NVIDIA, Micron, and SanDisk as investors weigh...